Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Retraction: In Vitro and In Vivo Interactions between the HDAC6 Inhibitor Ricolinostat (ACY1215) and the Irreversible Proteasome Inhibitor Carfilzomib in Non-Hodgkin Lymphoma Cells.

Dasmahapatra G, Patel H, Friedberg J, Quayle SN, Jones SS, Grant S.

Mol Cancer Ther. 2019 Jun;18(6):1181. doi: 10.1158/1535-7163.MCT-19-0471. No abstract available.

2.

The Impact of Pre-Exposure Prophylaxis (PrEP) Use on Sexual Anxiety, Satisfaction, and Esteem Among Gay and Bisexual Men.

Whitfield THF, Jones SS, Wachman M, Grov C, Parsons JT, Rendina HJ.

J Sex Res. 2019 Nov-Dec;56(9):1128-1135. doi: 10.1080/00224499.2019.1572064. Epub 2019 Feb 19.

PMID:
30777781
3.

HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics.

Laino AS, Betts BC, Veerapathran A, Dolgalev I, Sarnaik A, Quayle SN, Jones SS, Weber JS, Woods DM.

J Immunother Cancer. 2019 Feb 6;7(1):33. doi: 10.1186/s40425-019-0517-0.

4.

Development and Evaluation of a Machine Learning Model for the Early Identification of Patients at Risk for Sepsis.

Delahanty RJ, Alvarez J, Flynn LM, Sherwin RL, Jones SS.

Ann Emerg Med. 2019 Apr;73(4):334-344. doi: 10.1016/j.annemergmed.2018.11.036. Epub 2019 Jan 17.

PMID:
30661855
5.

Novel genetic code and record-setting AT-richness in the highly reduced plastid genome of the holoparasitic plant Balanophora.

Su HJ, Barkman TJ, Hao W, Jones SS, Naumann J, Skippington E, Wafula EK, Hu JM, Palmer JD, dePamphilis CW.

Proc Natl Acad Sci U S A. 2019 Jan 15;116(3):934-943. doi: 10.1073/pnas.1816822116. Epub 2018 Dec 31.

6.

Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia.

Maharaj K, Powers JJ, Achille A, Deng S, Fonseca R, Pabon-Saldana M, Quayle SN, Jones SS, Villagra A, Sotomayor EM, Sahakian E, Pinilla-Ibarz J.

Blood Adv. 2018 Nov 13;2(21):3012-3024. doi: 10.1182/bloodadvances.2018020065.

7.

Effective Home Visiting Training: Key Principles and Findings to Guide Training Developers and Evaluators.

Schultz D, Jones SS, Pinder WM, Wiprovnick AE, Groth EC, Shanty LM, Duggan A.

Matern Child Health J. 2018 Nov;22(11):1563-1567. doi: 10.1007/s10995-018-2554-6. Review.

PMID:
29936655
8.

Development and Evaluation of an Automated Machine Learning Algorithm for In-Hospital Mortality Risk Adjustment Among Critical Care Patients.

Delahanty RJ, Kaufman D, Jones SS.

Crit Care Med. 2018 Jun;46(6):e481-e488. doi: 10.1097/CCM.0000000000003011.

PMID:
29419557
9.

The case against newborn imitation grows stronger.

Jones SS.

Behav Brain Sci. 2017 Jan;40:e391. doi: 10.1017/S0140525X16001886.

PMID:
29342822
10.

HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia.

Tharkar-Promod S, Johnson DP, Bennett SE, Dennis EM, Banowsky BG, Jones SS, Shearstone JR, Quayle SN, Min C, Jarpe M, Mosbruger T, Pomicter AD, Miles RR, Chen WY, Bhalla KN, Zweidler-McKay PA, Shrieve DC, Deininger MW, Chandrasekharan MB, Bhaskara S.

Leukemia. 2018 Jan;32(1):49-60. doi: 10.1038/leu.2017.174. Epub 2017 Jun 5.

11.

Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-Small Cell Lung Cancer.

Adeegbe DO, Liu Y, Lizotte PH, Kamihara Y, Aref AR, Almonte C, Dries R, Li Y, Liu S, Wang X, Warner-Hatten T, Castrillon J, Yuan GC, Poudel-Neupane N, Zhang H, Guerriero JL, Han S, Awad MM, Barbie DA, Ritz J, Jones SS, Hammerman PS, Bradner J, Quayle SN, Wong KK.

Cancer Discov. 2017 Aug;7(8):852-867. doi: 10.1158/2159-8290.CD-16-1020. Epub 2017 Apr 13.

12.

Enhancement of pomalidomide anti-tumor response with ACY-241, a selective HDAC6 inhibitor.

North BJ, Almeciga-Pinto I, Tamang D, Yang M, Jones SS, Quayle SN.

PLoS One. 2017 Mar 6;12(3):e0173507. doi: 10.1371/journal.pone.0173507. eCollection 2017.

13.

Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia.

Min C, Moore N, Shearstone JR, Quayle SN, Huang P, van Duzer JH, Jarpe MB, Jones SS, Yang M.

PLoS One. 2017 Jan 6;12(1):e0169128. doi: 10.1371/journal.pone.0169128. eCollection 2017.

14.

Ricolinostat, the First Selective Histone Deacetylase 6 Inhibitor, in Combination with Bortezomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma.

Vogl DT, Raje N, Jagannath S, Richardson P, Hari P, Orlowski R, Supko JG, Tamang D, Yang M, Jones SS, Wheeler C, Markelewicz RJ, Lonial S.

Clin Cancer Res. 2017 Jul 1;23(13):3307-3315. doi: 10.1158/1078-0432.CCR-16-2526. Epub 2017 Jan 4.

15.

Selective HDAC inhibition by ACY-241 enhances the activity of paclitaxel in solid tumor models.

Huang P, Almeciga-Pinto I, Jarpe M, van Duzer JH, Mazitschek R, Yang M, Jones SS, Quayle SN.

Oncotarget. 2017 Jan 10;8(2):2694-2707. doi: 10.18632/oncotarget.13738.

16.

Impact of Palliative Care Screening and Consultation in the ICU: A Multihospital Quality Improvement Project.

Zalenski RJ, Jones SS, Courage C, Waselewsky DR, Kostaroff AS, Kaufman D, Beemath A, Brofman J, Castillo JW, Krayem H, Marinelli A, Milner B, Palleschi MT, Tareen M, Testani S, Soubani A, Walch J, Wheeler J, Wilborn S, Granovsky H, Welch RD.

J Pain Symptom Manage. 2017 Jan;53(1):5-12.e3. doi: 10.1016/j.jpainsymman.2016.08.003. Epub 2016 Oct 5.

PMID:
27720791
17.

Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial.

Yee AJ, Bensinger WI, Supko JG, Voorhees PM, Berdeja JG, Richardson PG, Libby EN, Wallace EE, Birrer NE, Burke JN, Tamang DL, Yang M, Jones SS, Wheeler CA, Markelewicz RJ, Raje NS.

Lancet Oncol. 2016 Nov;17(11):1569-1578. doi: 10.1016/S1470-2045(16)30375-8. Epub 2016 Sep 17.

PMID:
27646843
18.

Chemical Inhibition of Histone Deacetylases 1 and 2 Induces Fetal Hemoglobin through Activation of GATA2.

Shearstone JR, Golonzhka O, Chonkar A, Tamang D, van Duzer JH, Jones SS, Jarpe MB.

PLoS One. 2016 Apr 13;11(4):e0153767. doi: 10.1371/journal.pone.0153767. eCollection 2016.

19.

Detecting and Characterizing the Highly Divergent Plastid Genome of the Nonphotosynthetic Parasitic Plant Hydnora visseri (Hydnoraceae).

Naumann J, Der JP, Wafula EK, Jones SS, Wagner ST, Honaas LA, Ralph PE, Bolin JF, Maass E, Neinhuis C, Wanke S, dePamphilis CW.

Genome Biol Evol. 2016 Jan 6;8(2):345-63. doi: 10.1093/gbe/evv256.

20.

Relations among early object recognition skills: Objects and letters.

Augustine E, Jones SS, Smith LB, Longfield E.

J Cogn Dev. 2015 Apr 1;16(2):221-235.

21.

The value of health information technology: filling the knowledge gap.

Rudin RS, Jones SS, Shekelle P, Hillestad RJ, Keeler EB.

Am J Manag Care. 2014 Nov;20(11 Spec No. 17):eSP1-8.

22.

Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma cell death.

Mishima Y, Santo L, Eda H, Cirstea D, Nemani N, Yee AJ, O'Donnell E, Selig MK, Quayle SN, Arastu-Kapur S, Kirk C, Boise LH, Jones SS, Raje N.

Br J Haematol. 2015 May;169(3):423-34. doi: 10.1111/bjh.13315. Epub 2015 Feb 23.

PMID:
25709080
23.

A cultural understanding of Chinese immigrant mothers' feeding practices. A qualitative study.

Zhou N, Cheah CS, Van Hook J, Thompson DA, Jones SS.

Appetite. 2015 Apr;87:160-7. doi: 10.1016/j.appet.2014.12.215. Epub 2014 Dec 30.

24.

Young Children's Self-Generated Object Views and Object Recognition.

James KH, Jones SS, Smith LB, Swain SN.

J Cogn Dev. 2014;15(3):393-401. No abstract available.

25.

Ciprofloxacin residues in municipal biosolid compost do not selectively enrich populations of resistant bacteria.

Youngquist CP, Liu J, Orfe LH, Jones SS, Call DR.

Appl Environ Microbiol. 2014 Dec;80(24):7521-6. doi: 10.1128/AEM.02899-14. Epub 2014 Sep 26.

26.

In vitro and in vivo interactions between the HDAC6 inhibitor ricolinostat (ACY1215) and the irreversible proteasome inhibitor carfilzomib in non-Hodgkin lymphoma cells.

Dasmahapatra G, Patel H, Friedberg J, Quayle SN, Jones SS, Grant S.

Mol Cancer Ther. 2014 Dec;13(12):2886-97. doi: 10.1158/1535-7163.MCT-14-0220. Epub 2014 Sep 19. Retraction in: Mol Cancer Ther. 2019 Jun;18(6):1181.

27.

The Future of Health Care in the Kurdistan Region - Iraq: Toward an Effective, High-Quality System with an Emphasis on Primary Care.

Moore M, Anthony CR, Lim YW, Jones SS, Overton A, Yoong JK.

Rand Health Q. 2014 Jun 1;4(2):1. eCollection 2014 Summer.

28.

Using the axis of elongation to align shapes: developmental changes between 18 and 24 months of age.

Smith LB, Street S, Jones SS, James KH.

J Exp Child Psychol. 2014 Jul;123:15-35. doi: 10.1016/j.jecp.2014.01.009. Epub 2014 Mar 17.

29.

Health information technology: an updated systematic review with a focus on meaningful use.

Jones SS, Rudin RS, Perry T, Shekelle PG.

Ann Intern Med. 2014 Jan 7;160(1):48-54. doi: 10.7326/M13-1531. Review.

PMID:
24573664
30.

Genomics education for the public: perspectives of genomic researchers and ELSI advisors.

Dressler LG, Jones SS, Markey JM, Byerly KW, Roberts MC.

Genet Test Mol Biomarkers. 2014 Mar;18(3):131-40. doi: 10.1089/gtmb.2013.0366. Epub 2014 Feb 4.

31.

Some views are better than others: evidence for a visual bias in object views self-generated by toddlers.

James KH, Jones SS, Swain S, Pereira A, Smith LB.

Dev Sci. 2014 May;17(3):338-51. doi: 10.1111/desc.12124. Epub 2014 Jan 11.

32.

Stunting of Onion in the Columbia Basin of Oregon and Washington Caused by Rhizoctonia spp.

Patzek LJ, du Toit LJ, Paulitz TC, Jones SS.

Plant Dis. 2013 Dec;97(12):1626-1635. doi: 10.1094/PDIS-04-13-0385-RE.

PMID:
30716865
33.

Primary care technicians: a solution to the primary care workforce gap.

Kellermann AL, Saultz JW, Mehrotra A, Jones SS, Dalal S.

Health Aff (Millwood). 2013 Nov;32(11):1893-8. doi: 10.1377/hlthaff.2013.0481.

PMID:
24191077
34.

CMS Innovation Center Health Care Innovation Awards: Evaluation Plan.

Berry SH, Concannon TW, Morganti KG, Auerbach DI, Beckett MK, Chen PG, Farley DO, Han B, Harris KM, Jones SS, Liu H, Lovejoy SL, Marsh T, Martsolf GR, Nelson C, Okeke EN, Pearson ML, Pillemer F, Sorbero ME, Towe V, Weinick RM.

Rand Health Q. 2013 Sep 1;3(3):1. eCollection 2013 Fall.

35.

Histone deacetylase (HDAC) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDAC.

Mithraprabhu S, Khong T, Jones SS, Spencer A.

Br J Haematol. 2013 Aug;162(4):559-62. doi: 10.1111/bjh.12388. Epub 2013 May 21. No abstract available.

PMID:
23692150
36.

Health information technology: authors' reply.

Kellermann AL, Jones SS.

Health Aff (Millwood). 2013 Mar;32(3):629. doi: 10.1377/hlthaff.2013.0092. No abstract available.

PMID:
23459744
37.

What it will take to achieve the as-yet-unfulfilled promises of health information technology.

Kellermann AL, Jones SS.

Health Aff (Millwood). 2013 Jan;32(1):63-8. doi: 10.1377/hlthaff.2012.0693.

PMID:
23297272
38.

Human toddlers' attempts to match two simple behaviors provide no evidence for an inherited, dedicated imitation mechanism.

Jones SS.

PLoS One. 2012;7(12):e51326. doi: 10.1371/journal.pone.0051326. Epub 2012 Dec 10.

39.

Changes in visual object recognition precede the shape bias in early noun learning.

Yee M, Jones SS, Smith LB.

Front Psychol. 2012 Dec 3;3:533. doi: 10.3389/fpsyg.2012.00533. eCollection 2012.

40.

Reduction of peripherally inserted central catheter-associated DVT.

Evans RS, Sharp JH, Linford LH, Lloyd JF, Woller SC, Stevens SM, Elliott CG, Tripp JS, Jones SS, Weaver LK.

Chest. 2013 Mar;143(3):627-633. doi: 10.1378/chest.12-0923.

PMID:
22878346
41.

Unraveling the IT productivity paradox--lessons for health care.

Jones SS, Heaton PS, Rudin RS, Schneider EC.

N Engl J Med. 2012 Jun 14;366(24):2243-5. doi: 10.1056/NEJMp1204980. No abstract available.

PMID:
22693996
42.

Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma.

Santo L, Hideshima T, Kung AL, Tseng JC, Tamang D, Yang M, Jarpe M, van Duzer JH, Mazitschek R, Ogier WC, Cirstea D, Rodig S, Eda H, Scullen T, Canavese M, Bradner J, Anderson KC, Jones SS, Raje N.

Blood. 2012 Mar 15;119(11):2579-89. doi: 10.1182/blood-2011-10-387365. Epub 2012 Jan 19.

43.

Health information exchange, Health Information Technology use, and hospital readmission rates.

Jones SS, Friedberg MW, Schneider EC.

AMIA Annu Symp Proc. 2011;2011:644-53. Epub 2011 Oct 22.

44.

NMR analysis of metabolic responses to extreme conditions of the temperature-dependent coral pathogen Vibrio coralliilyticus.

Boroujerdi AF, Jones SS, Bearden DW.

Lett Appl Microbiol. 2012 Mar;54(3):209-16. doi: 10.1111/j.1472-765X.2011.03200.x.

45.

Vision for action in toddlers: the posting task.

Street SY, James KH, Jones SS, Smith LB.

Child Dev. 2011 Nov-Dec;82(6):2083-94. doi: 10.1111/j.1467-8624.2011.01655.x. Epub 2011 Oct 17.

46.

The effects of PRX-07034, a novel 5-HT6 antagonist, on cognitive flexibility and working memory in rats.

Mohler EG, Baker PM, Gannon KS, Jones SS, Shacham S, Sweeney JA, Ragozzino ME.

Psychopharmacology (Berl). 2012 Apr;220(4):687-96. doi: 10.1007/s00213-011-2518-7. Epub 2011 Oct 12.

47.

Parts and Relations in Young Children's Shape-Based Object Recognition.

Augustine E, Smith LB, Jones SS.

J Cogn Dev. 2011 Oct;12(4). doi: 10.1080/15248372.2011.560586.

48.

Today's 'meaningful use' standard for medication orders by hospitals may save few lives; later stages may do more.

Jones SS, Heaton P, Friedberg MW, Schneider EC.

Health Aff (Millwood). 2011 Oct;30(10):2005-12. doi: 10.1377/hlthaff.2011.0245. Epub 2011 Sep 14.

PMID:
21918179
49.

Symbolic play connects to language through visual object recognition.

Smith LB, Jones SS.

Dev Sci. 2011 Sep;14(5):1142-9. doi: 10.1111/j.1467-7687.2011.01065.x. Epub 2011 Jul 20.

50.

The Role of Consumer-Controlled Personal Health Management Systems in the Evolution of Employer-Based Health Care Benefits.

Jones SS, Caloyeras J, Mattke S.

Rand Health Q. 2011 Sep 1;1(3):2. eCollection 2011 Fall.

Supplemental Content

Loading ...
Support Center